Table 1.
Variable | Participants (n = 32) |
---|---|
Age (years) | 47.8 ± 13.7 |
BMI (m/kg2) | 26.5 ± 3.1 |
Time elapsed since diagnoses (years) | 9.4 ± 6.6 |
Drugs: n (%) | |
No drugs | 03/32 (9.3%) |
Antidepressants | 21/32 (65.6%) |
Analgesic | 11/32 (34.3%) |
Muscular relaxant | 17/32 (53.1%) |
NSAIDS | 05/32 (15.6%) |
Opioids | 04/32 (12.5%) |
Comorbidities: n (%) | |
Osteoarthritis | 02/32 (6.2%) |
Arterial hypertension | 09/32 (28.1%) |
Dyslipidemia | 04/32 (12.5%) |
Diabetes mellitus | 05/32 (16.6%) |
Osteoporosis | 06/32 (18.7%) |
Asthma | 01/32 (3.1%) |
1-RM Leg press (kg) | 144.5 ± 47.6 |
1-RM Bench press (kg) | 27.2 ± 6.3 |
SF-MPQ pre | 22.6 ± 15.8 |
VAS pre | 4.2 ± 2.7 |
Data expressed as mean ± SD or n (percentage of the sample). Abbreviations: (1-RM) 1-repetition maximum, (RPE) Rating of Perceived Exertion, (VAS) Visual Analogic Scale, (SF-MPQ) Short-Form McGill Pain Questionnaire.